{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:32:53Z","timestamp":1762867973869,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11845-019-02127-z","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T07:02:48Z","timestamp":1573455768000},"page":"529-534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Current role of the collagenase Clostridium histolyticum in Dupuytren\u2019s disease treatment"],"prefix":"10.1007","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-0987","authenticated-orcid":false,"given":"Rafael","family":"Sanjuan-Cervero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"2127_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11552-010-9306-4","volume":"6","author":"DB Dibenedetti","year":"2011","unstructured":"Dibenedetti DB, Nguyen D, Zografos L et al (2011) Prevalence, incidence, and treatments of Dupuytren\u2019s disease in the United States: results from a population-based study. Hand N Y N 6:149\u2013158","journal-title":"Hand N Y N"},{"key":"2127_CR2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/annrheumdis-2012-201295","volume":"71","author":"B Shih","year":"2012","unstructured":"Shih B, Watson S, Bayat A (2012) Whole genome and global expression profiling of Dupuytren\u2019s disease: systematic review of current findings and future perspectives. Ann Rheum Dis 71:1440\u20131447","journal-title":"Ann Rheum Dis"},{"key":"2127_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2106\/00004623-198163050-00014","volume":"63","author":"D Brickley-Parsons","year":"1981","unstructured":"Brickley-Parsons D, Glimcher MJ, Smith RJ et al (1981) Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren\u2019s disease. J Bone Jt Surg Am 63:787\u2013797","journal-title":"J Bone Jt Surg Am"},{"key":"2127_CR4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz B, Phan SH, Thannickal VJ et al (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170:1807\u20131816","journal-title":"Am J Pathol"},{"key":"2127_CR5","first-page":"349","volume":"11","author":"JI Hueston","year":"1992","unstructured":"Hueston JI (1992) Lessons in Dupuytren\u2019s disease. Ann Chir Main Memb Sup\u00e9r 11:349\u2013354","journal-title":"Ann Chir Main Memb Sup\u00e9r"},{"key":"2127_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0007-1226(63)80121-6","volume":"16","author":"P Clarkson","year":"1963","unstructured":"Clarkson P (1963) The radical fasciectomy operation for Dupuytren\u2019s disease: a condemnation. Br J Plast Surg 16:273\u2013279","journal-title":"Br J Plast Surg"},{"key":"2127_CR7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1169-8330(01)00035-7","volume":"68","author":"J-L Lermusiaux","year":"2001","unstructured":"Lermusiaux J-L, Badois F, Lellouche H (2001) Maladie de Dupuytren. Rev Rhum 68:542\u2013547","journal-title":"Rev Rhum"},{"key":"2127_CR8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/ijcp.12106","volume":"67","author":"J Dias","year":"2013","unstructured":"Dias J, Bainbridge C, Leclercq C et al (2013) Surgical management of Dupuytren\u2019s contracture in Europe: regional analysis of a surgeon survey and patient chart review. Int J Clin Pract 67:271\u2013281","journal-title":"Int J Clin Pract"},{"key":"2127_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/1040841X.2014.904270","volume":"42","author":"AS Duarte","year":"2016","unstructured":"Duarte AS, Correia A, Esteves AC (2016) Bacterial collagenases - a review. Crit Rev Microbiol 42:106\u2013126","journal-title":"Crit Rev Microbiol"},{"key":"2127_CR10","unstructured":"Worthington V Collagenase - Worthington Enzyme Manual. Worthington Enzyme Manual, Worthington K, Worthington V (2011) Worthington Biochemical Corporation., http:\/\/www.worthington-biochem.com\/cls\/default.html (2011, accessed 20 August 2017)."},{"key":"2127_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/JB.34.4.387-407.1937","volume":"34","author":"JC Hoogerheide","year":"1937","unstructured":"Hoogerheide JC (1937) Variability in morphological and biochemical properties of Clostridium histolyticum (Weinberg and Seguin). J Bacteriol 34:387\u2013407","journal-title":"J Bacteriol"},{"key":"2127_CR12","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/bi00308a036","volume":"23","author":"MD Bond","year":"1984","unstructured":"Bond MD, Van Wart HE (1984) Characterization of the individual collagenases from Clostridium histolyticum. Biochemistry 23:3085\u20133091","journal-title":"Biochemistry"},{"key":"2127_CR13","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1021\/bi00308a035","volume":"23","author":"MD Bond","year":"1984","unstructured":"Bond MD, Van Wart HE (1984) Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography. Biochemistry 23:3077\u20133085","journal-title":"Biochemistry"},{"key":"2127_CR14","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1021\/bi00308a037","volume":"23","author":"MD Bond","year":"1984","unstructured":"Bond MD, Van Wart HE (1984) Relationship between the individual collagenases of Clostridium histolyticum: evidence for evolution by gene duplication. Biochemistry 23:3092\u20133099","journal-title":"Biochemistry"},{"key":"2127_CR15","first-page":"8","volume":"18","author":"R Sanjuan-Cerver\u00f3","year":"2016","unstructured":"Sanjuan-Cerver\u00f3 R, Gomez-Herrero D, Carrera-Hueso FJ (2016) Mechanism of action of collagenase clostridium histolyticum for clinical application. Eur J Clin Pharm Aten Farm 18:8\u20138","journal-title":"Eur J Clin Pharm Aten Farm"},{"key":"2127_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00007632-198003000-00006","volume":"5","author":"JW Bromley","year":"1980","unstructured":"Bromley JW, Hirst JW, Osman M, Steinlauf P, Gennace RE, Stern H (1980) Collagenase: an experimental study of intervertebral disc dissolution. Spine 5:126\u2013132","journal-title":"Spine"},{"key":"2127_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00255956","volume":"10","author":"MK Gelbard","year":"1982","unstructured":"Gelbard MK, Walsh R, Kaufman JJ (1982) Collagenase for Peyronie\u2019s disease experimental studies. Urol Res 10:135\u2013140","journal-title":"Urol Res"},{"key":"2127_CR18","doi-asserted-by":"crossref","unstructured":"Badalamente MA, Hurst LC Collagenase: preclinical evaluation and clinical trials in the USA and Australia. In: Collagenase in Dupuytren Disease. Springer, Cham, pp 7\u201316","DOI":"10.1007\/978-3-319-65822-3_2"},{"key":"2127_CR19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.hcl.2018.03.004","volume":"34","author":"MA Badalamente","year":"2018","unstructured":"Badalamente MA, Hurst LC (2018) Development of collagenase treatment for Dupuytren disease. Hand Clin 34:345\u2013349","journal-title":"Hand Clin"},{"key":"2127_CR20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","volume":"361","author":"LC Hurst","year":"2009","unstructured":"Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J, CORD I Study Group (2009) Injectable collagenase Clostridium histolyticum for Dupuytren\u2019s contracture. N Engl J Med 361:968\u2013979","journal-title":"N Engl J Med"},{"key":"2127_CR21","doi-asserted-by":"crossref","first-page":"2027-2038.e1","DOI":"10.1016\/j.jhsa.2010.08.007","volume":"35","author":"D Gilpin","year":"2010","unstructured":"Gilpin D, Coleman S, Hall S et al (2010) Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren\u2019s disease. J Hand Surg 35:2027-2038.e1","journal-title":"J Hand Surg"},{"key":"2127_CR22","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.jhsa.2013.08.114","volume":"38","author":"CA Peimer","year":"2013","unstructured":"Peimer CA, Skodny P, Mackowiak JI (2013) Collagenase Clostridium histolyticum for Dupuytren contracture: patterns of use and effectiveness in clinical practice. J Hand Surg 38:2370\u20132376","journal-title":"J Hand Surg"},{"key":"2127_CR23","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","volume":"40","author":"CA Peimer","year":"2015","unstructured":"Peimer CA, Blazar P, Coleman S et al (2015) Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data. J Hand Surg 40:1597\u20131605","journal-title":"J Hand Surg"},{"key":"2127_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1753193413519926","volume":"40","author":"D Warwick","year":"2015","unstructured":"Warwick D, Arner M, Pajardi G et al (2015) Collagenase clostridium histolyticum in patients with Dupuytren\u2019s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes. J Hand Surg Eur Vol 40:124\u2013132","journal-title":"J Hand Surg Eur Vol"},{"key":"2127_CR25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1753193416653249","volume":"42","author":"H Hirata","year":"2016","unstructured":"Hirata H, Tanaka K, Sakai A et al (2016) Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren\u2019s contracture in non-Caucasian Japanese patients (CORD-J Study): the first clinical trial in a non-Caucasian population. J Hand Surg Eur Vol 42:30\u201338","journal-title":"J Hand Surg Eur Vol"},{"key":"2127_CR26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bjps.2014.10.011","volume":"68","author":"E Bebbington","year":"2015","unstructured":"Bebbington E, Furniss D (2015) Linear regression analysis of Hospital Episode Statistics predicts a large increase in demand for elective hand surgery in England. J Plast Reconstr Aesthet Surg 68:243\u2013251","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2127_CR27","first-page":"1826-1834.e32","volume":"36","author":"NC Chen","year":"2011","unstructured":"Chen NC, Shauver MJ, Chung KC (2011) Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg 36:1826-1834.e32","journal-title":"J Hand Surg"},{"key":"2127_CR28","doi-asserted-by":"crossref","first-page":"A38","DOI":"10.1016\/j.jval.2012.03.218","volume":"15","author":"DC Malone","year":"2012","unstructured":"Malone DC, Armstrong EP (2012) PMS29 Cost-Effectiveness of collagenase Clostridium histolyticum, limited fasciectomy, and percutaneous needle fasciotomy in the treatment of Dupuytren\u2019s contracture. Value Health 15:A38\u2013A39","journal-title":"Value Health"},{"key":"2127_CR29","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1302\/0301-620X.95B8.31822","volume":"95-B","author":"H Baltzer","year":"2013","unstructured":"Baltzer H, Binhammer PA (2013) Cost-effectiveness in the management of Dupuytren\u2019s contracture a Canadian cost-utility analysis of current and future management strategies. Bone Jt J 95-B:1094\u20131100","journal-title":"Bone Jt J"},{"key":"2127_CR30","doi-asserted-by":"crossref","unstructured":"Sanjuan-Cervero R, Franco-Ferrando N, Poquet-Jornet JE et al Short-term cost-utility analysis of collagenase versus fasciectomy for Dupuytren contracture. In: Dupuytren Disease and Related Diseases - The Cutting Edge. Springer, Cham, pp 271\u2013275","DOI":"10.1007\/978-3-319-32199-8_36"},{"key":"2127_CR31","first-page":"94","volume":"86","author":"LE Murphy","year":"2017","unstructured":"Murphy LE, Murphy KM, Kilpatrick SM et al (2017) The use of collagenase Clostridium histolyticum in the management of Dupuytren\u2019s contracture-outcomes of a pilot study in a district general hospital setting. Ulst Med J 86:94\u201398","journal-title":"Ulst Med J"},{"key":"2127_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12891-018-1949-2","volume":"19","author":"M Dritsaki","year":"2018","unstructured":"Dritsaki M, Rivero-Arias O, Gray A et al (2018) What do we know about managing Dupuytren\u2019s disease cost-effectively? BMC Musculoskelet Disord 19:34","journal-title":"BMC Musculoskelet Disord"},{"key":"2127_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2474-14-293","volume":"14","author":"R Sanjuan-Cerver\u00f3","year":"2013","unstructured":"Sanjuan-Cerver\u00f3 R, Franco-Ferrando N, Poquet-Jornet J (2013) Use of resources and costs associated with the treatment of Dupuytren\u2019s contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy. BMC Musculoskelet Disord 14:293","journal-title":"BMC Musculoskelet Disord"},{"key":"2127_CR34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1504\/IJHTM.2016.078360","volume":"15","author":"R-L Leskel\u00e4","year":"2016","unstructured":"Leskel\u00e4 R-L, Herse F, Torkki P et al (2016) Analysis of the adoption of new health technology: the case of Dupuytren\u2019s disease. Int J Healthc Technol Manag 15:210\u2013227","journal-title":"Int J Healthc Technol Manag"},{"key":"2127_CR35","doi-asserted-by":"crossref","first-page":"070","DOI":"10.1055\/s-0037-1608749","volume":"45","author":"R Sanjuan-Cerver\u00f3","year":"2017","unstructured":"Sanjuan-Cerver\u00f3 R, Vazquez-Ferreiro P, Gomez-Herrero D et al (2017) Efficacy of collagenase Clostridium histolyticum for Dupuytren disease: a systematic review. Rev Iberoam Cir Mano 45:070\u2013088","journal-title":"Rev Iberoam Cir Mano"},{"key":"2127_CR36","doi-asserted-by":"crossref","unstructured":"Warwick D Collagenase: what we may never know (a discussion). In: PMN W, Dias J, Eaton C et al (eds) Dupuytren Disease and Related Diseases - The Cutting Edge. Springer International Publishing, pp 145\u2013149","DOI":"10.1007\/978-3-319-32199-8_19"},{"key":"2127_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11552-013-9526-5","volume":"8","author":"J Jupiter","year":"2013","unstructured":"Jupiter J, Burke D (2013) Scott\u2019s parabola and the rise of the medical\u2013industrial complex. Hand N Y N 8:249\u2013252","journal-title":"Hand N Y N"},{"key":"2127_CR38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/bmj.323.7327.1477","volume":"323","author":"JW Scott","year":"2001","unstructured":"Scott JW (2001) Scott\u2019s parabola. BMJ 323:1477","journal-title":"BMJ"},{"key":"2127_CR39","doi-asserted-by":"crossref","unstructured":"Arandes-Ren\u00fa JM, Sanju\u00e1n-Cerver\u00f3 R, Moya-Molinas I Collagenase in Europe from the experimental phase to practical use. In: Pajardi G, Badalamente MA, Hurst LC (eds) Collagenase in Dupuytren Disease. Springer International Publishing, Cham, pp 39\u201374","DOI":"10.1007\/978-3-319-65822-3_4"},{"key":"2127_CR40","first-page":"105","volume":"31","author":"R Sanjuan-Cerver\u00f3","year":"2017","unstructured":"Sanjuan-Cerver\u00f3 R, Carrera-Hueso FJ, Vazquez-Ferreiro P et al (2017) Adverse effects of collagenase in the treatment of Dupuytren disease: a systematic review. BioDrugs Clin Immunother Biopharm Gene Ther 31:105\u2013115","journal-title":"BioDrugs Clin Immunother Biopharm Gene Ther"},{"key":"2127_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1753193414528843","volume":"40","author":"CA Peimer","year":"2015","unstructured":"Peimer CA, Wilbrand S, Gerber RA et al (2015) Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren\u2019s contracture. J Hand Surg Eur Vol 40:141\u2013149","journal-title":"J Hand Surg Eur Vol"},{"key":"2127_CR42","first-page":"21","volume":"7","author":"LW Lewallen","year":"2017","unstructured":"Lewallen LW, Rizzo M (2017) Phalangeal fracture during attempted Dupuytrens release following clostridial collagenase injection: case report. J Orthop Case Rep 7:21\u201324","journal-title":"J Orthop Case Rep"},{"key":"2127_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.9734\/IJMPCR\/2014\/12446","volume":"1","author":"R Sanjuan-Cerver\u00f3","year":"2014","unstructured":"Sanjuan-Cerver\u00f3 R, Franco N (2014) Vasospasm after collagenase Clostridium histolyticum infiltration in Dupuytren\u2019s contracture. Int J Med Pharm Case Rep 1:42\u201348","journal-title":"Int J Med Pharm Case Rep"},{"key":"2127_CR44","doi-asserted-by":"crossref","unstructured":"Wozniczka J, Canepa C, Mirarchi A et al (2017) Complications following collagenase treatment for Dupuytren contracture. HAND 1558944717711461","DOI":"10.1177\/1558944717711461"},{"key":"2127_CR45","doi-asserted-by":"crossref","unstructured":"Eaton C Controversy: the contracture in Dupuytren disease is a passive process. In: Werker PMN, Dias J, Eaton C et al (eds) Dupuytren Disease and Related Diseases - The Cutting Edge. Springer International Publishing, pp 89\u201396","DOI":"10.1007\/978-3-319-32199-8_11"},{"key":"2127_CR46","doi-asserted-by":"crossref","unstructured":"Hurst L Dupuytre's contracture. In: Green\u2019s Operative Hand Surgery. Churchill Livingstone, Edimburg, pp 141\u2013158","DOI":"10.1016\/B978-1-4160-5279-1.00005-8"},{"key":"2127_CR47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00402-015-2380-x","volume":"136","author":"B Hohendorff","year":"2016","unstructured":"Hohendorff B, Spies CK, M\u00fcller LP, Ries C (2016) Supplementary arthrolysis of the proximal interphalangeal finger joint in Dupuytren\u2019s contracture: primary operation versus revision. Arch Orthop Trauma Surg 136:435\u2013439","journal-title":"Arch Orthop Trauma Surg"},{"key":"2127_CR48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1302\/0301-620X.100B1.BJJ-2017-0463.R1","volume":"100-B","author":"R Sanjuan-Cerver\u00f3","year":"2018","unstructured":"Sanjuan-Cerver\u00f3 R, Carrera-Hueso FJ, Vazquez-Ferreiro P et al (2018) Efficacy and adverse effects of collagenase use in the treatment of Dupuytren\u2019s disease: a meta-analysis. Bone Jt J 100-B:73\u201380","journal-title":"Bone Jt J"},{"key":"2127_CR49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","volume":"38","author":"CA Peimer","year":"2013","unstructured":"Peimer CA, Blazar P, Coleman S et al (2013) Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS Study): 3-year data. J Hand Surg 38:12\u201322","journal-title":"J Hand Surg"},{"key":"2127_CR50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/1753193417715773","volume":"42","author":"D Warwick","year":"2017","unstructured":"Warwick D (2017) Dupuytren\u2019s disease: my personal view. J Hand Surg Eur Vol 42:665\u2013672","journal-title":"J Hand Surg Eur Vol"},{"key":"2127_CR51","doi-asserted-by":"crossref","unstructured":"Wilbrand S Collagenase: future perspectives. In: Pajardi G, Badalamente MA, Hurst LC (eds) Collagenase in Dupuytren Disease. Springer International Publishing, Cham, pp 131\u2013142","DOI":"10.1007\/978-3-319-65822-3_10"},{"key":"2127_CR52","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1302\/0301-620X.80B5.0800907","volume":"80-B","author":"JW Hutchinson","year":"1998","unstructured":"Hutchinson JW, Tierney GM, Parsons SL et al (1998) Dupuytren\u2019s disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor. J Bone Joint Surg Br 80-B:907\u2013908","journal-title":"J Bone Joint Surg Br"},{"key":"2127_CR53","doi-asserted-by":"publisher","unstructured":"Badalamente MA, Wang ED CORR(\u00ae) ORS Richard A. Brand award: clinical trials of a new treatment method for adhesive capsulitis. Clin Orthop. Epub ahead of print 9 May 2016. https:\/\/doi.org\/10.1007\/s11999-016-4862-8","DOI":"10.1007\/s11999-016-4862-8"},{"key":"2127_CR54","doi-asserted-by":"publisher","unstructured":"Diehm YF, Hirche C, Berger MR et al The collagenase of the bacterium Clostridium histolyticum in the treatment of irradiation-induced capsular contracture. Aesthetic Plast Surg. Epub ahead of print 19 November 2018. https:\/\/doi.org\/10.1007\/s00266-018-1267-y","DOI":"10.1007\/s00266-018-1267-y"},{"key":"2127_CR55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00266-016-0724-8","volume":"41","author":"S Fischer","year":"2017","unstructured":"Fischer S, Diehm Y, Henzler T, Berger MR, Kolbenschlag J, Latz A, Bueno EM, Hirche C, Kneser U, Pomahac B (2017) Long-Term Effects of the Collagenase of the Bacterium Clostridium histolyticum for the Treatment of Capsular Fibrosis After Silicone Implants. Aesthetic Plast Surg 41:211\u2013220","journal-title":"Aesthetic Plast Surg"},{"key":"2127_CR56","unstructured":"Badalemente MA, Wang E (2009) Methods for treatment using collagenase. 20090010918, http:\/\/www.freepatentsonline.com\/y2009\/0010918.html (accessed 21 October 2017)."},{"key":"2127_CR57","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/BOR.0b013e32830e48e8","volume":"20","author":"J Varga","year":"2008","unstructured":"Varga J, Pasche B (2008) Anti-TGF-\u00df Therapy in Fibrosis: recent progress and implications for systemic sclerosis. Curr Opin Rheumatol 20:720\u2013728","journal-title":"Curr Opin Rheumatol"},{"key":"2127_CR58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12891-016-1326-y","volume":"17","author":"C Zhou","year":"2016","unstructured":"Zhou C, Liu F, Gallo PH et al (2016) Anti-fibrotic action of pirfenidone in Dupuytren\u2019s disease-derived fibroblasts. BMC Musculoskelet Disord 17:469","journal-title":"BMC Musculoskelet Disord"},{"key":"2127_CR59","doi-asserted-by":"publisher","unstructured":"Villegas MR, Baeza A, Usategui A et al Collagenase nanocapsules: an approach to fibrosis treatment. Acta Biomater. Epub ahead of print 4 May 2018. https:\/\/doi.org\/10.1016\/j.actbio.2018.05.007","DOI":"10.1016\/j.actbio.2018.05.007"},{"key":"2127_CR60","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/10717544.2018.1474971","volume":"25","author":"A Pan","year":"2018","unstructured":"Pan A, Wang Z, Chen B, Dai W, Zhang H, He B, Wang X, Wang Y, Zhang Q (2018) Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft. Drug Deliv 25:1495\u20131503","journal-title":"Drug Deliv"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-019-02127-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-019-02127-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-019-02127-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:51:40Z","timestamp":1604969500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-019-02127-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1007\/s11845-019-02127-z","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"19 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Research involving human participants and\/or animals review. Non clinical study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Not necessary. Review article made without patients participation. Non clinical study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}